​

DiaMedica Therapeutics Ownership | Who Owns DiaMedica Therapeutics?

OverviewForecastFinancialsChartTranscripts

DiaMedica Therapeutics Ownership Summary

DiaMedica Therapeutics is owned by 15.74% institutional investors, 26.21% insiders, and 58.05% retail investors. Cooperman leon g is the largest institutional shareholder, holding 3.80% of DMAC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.00% of its assets in DiaMedica Therapeutics shares.

DMAC Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockDiaMedica Therapeutics15.74%26.21%58.05%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Cooperman leon g1.63M3.80%$8.82M
Vanguard group1.24M2.91%$6.74M
First manhattan co. llc.839.08K1.96%$4.56M
Paragon associates & paragon associates ii joint venture514.78K1.20%$2.80M
Bleichroeder lp382.32K0.89%$2.08M
Susquehanna group, llp374.85K0.88%$2.04M
Geode capital management305.75K0.72%$1.66M
Lpl financial152.00K0.36%$825.36K
Northern trust120.39K0.32%$355.15K
Blackrock105.30K0.28%$310.64K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Paragon associates & paragon associates ii joint venture514.78K6.46%$2.80M
Bleichroeder lp382.32K0.52%$2.08M
Cooperman leon g1.63M0.33%$8.82M
Catalyst financial partners38.46K0.04%$208.82K
Magnolia capital advisors10.16K0.03%$55.17M
683 capital management76.12K0.03%$413.31K
First manhattan co. llc.839.08K0.01%$4.56M
Stonebridge capital advisors17.50K0.01%$95.03K
Naples money management2.98K0.01%$8.79K
Meridian wealth management27.22K0.01%$147.78K

Top Buyers

HolderShares% AssetsChange
Susquehanna group, llp374.85K0.00%273.39K
Vanguard group1.24M0.00%193.08K
Cooperman leon g1.63M0.33%113.26K
683 capital management76.12K0.03%76.12K
Goldman sachs group68.95K0.00%68.95K

Top Sellers

HolderShares% AssetsChange
Aristides capital---106.33K
Bank of new york mellon---24.00K
Ubs group1.77K--10.97K
Point72 asia (singapore) pte.---9.50K
Northern trust120.39K0.00%-7.43K

New Positions

HolderShares% AssetsChangeValue
683 capital management76.12K0.03%76.12K$413.31K
Goldman sachs group68.95K0.00%68.95K$374.39K
Barclays27.73K-27.73K$151.00K
Meridian wealth management27.22K0.01%27.22K$147.78K
Schonfeld strategic advisors26.10K0.00%26.10K$141.71K

Sold Out

HolderChange
Toronto dominion bank-24.00
Jpmorgan chase-27.00
Wells fargo & company/mn-175.00
Federation des caisses desjardins du quebec-230.00
Tower research capital llc (trc)-1.12K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20244711.90%6,729,01220.58%159.24%2827.27%5-16.67%
Sep 30, 20244223.53%5,580,41110.22%137.34%2283.33%6-33.33%
Jun 30, 202434-5,063,14310.09%136.69%1250.00%912.50%
Mar 31, 202434-15.00%4,599,12919.69%1413.77%8-55.56%8100.00%
Dec 31, 2023402.56%3,842,585-9.61%104.18%18-10.00%4-42.86%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv857.67K2.00%-
Vanguard US Total Market Shares ETF747.20K1.74%-
Vanguard Institutional Extnd Mkt Idx Tr446.81K1.04%-
Fidelity Extended Market Index143.78K0.34%-916.00
Jacob Discovery Fd Instl98.73K0.23%-24.00K
iShares Micro-Cap ETF54.74K0.13%-
Fidelity Total Market Index48.49K0.11%-39.00
Fidelity Nasdaq Composite Index42.74K0.10%-
BlackRock Extended Equity Market K39.62K0.09%-17.00
Extended Equity Market Fund K39.20K0.09%120.00

Recent Insider Transactions

DateNameRoleActivityValue
Jun 28, 2024Von Koch Thomas-Buy$3.00M
Jun 28, 2024STAHLBERG JAN-Buy$3.00M
Nov 16, 2023Wambeke David J. Chief Business OfficerBuy$49.20K
Jun 23, 2023Von Koch Thomas-Buy$5.00M
Jun 23, 2023Giuffre Randall Michael-Buy$254.15K

Insider Transactions Trends

DateBuySell
2025 Q2--
2025 Q1--
2024 Q22-
2024 Q1--
2023 Q41-

DMAC Ownership FAQ

Who Owns DiaMedica Therapeutics?

DiaMedica Therapeutics shareholders are primarily institutional investors at 15.74%, followed by 26.21% insiders and 58.05% retail investors. The average institutional ownership in DiaMedica Therapeutics's industry, Biotech Stocks , is 68.48%, which DiaMedica Therapeutics falls below.

Who owns the most shares of DiaMedica Therapeutics?

DiaMedica Therapeutics’s largest shareholders are Cooperman leon g (1.62M shares, 3.80%), Vanguard group (1.24M shares, 2.91%), and First manhattan co. llc. (839.08K shares, 1.96%). Together, they hold 8.67% of DiaMedica Therapeutics’s total shares outstanding.

Does Blackrock own DiaMedica Therapeutics?

Yes, BlackRock owns 0.28% of DiaMedica Therapeutics, totaling 105.3K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 310.64K$. In the last quarter, BlackRock increased its holdings by 1.93K shares, a 1.87% change.

Who is DiaMedica Therapeutics’s biggest shareholder by percentage of total assets invested?

Paragon associates & paragon associates ii joint venture is DiaMedica Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.46% of its assets in 514.78K DiaMedica Therapeutics shares, valued at 2.8M$.

Who is the top mutual fund holder of DiaMedica Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of DiaMedica Therapeutics shares, with 2.00% of its total shares outstanding invested in 857.67K DiaMedica Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools